Navigation Links
Online Fitness Tracker to Get You on Track –Just Get Moving

Dallas- With most spending every waking hour in front of the computer screen, any surprise that resolution //to stay fit in the new year is out of the window and no sooner, we are back to our sedentary lives once again.

While you recline and read this piece, the American Heart Association reiterates, the ‘inactive’ trend is disastrous for your heart. ‘Get moving’ they say as they inspire one and all with their online fitness and nutrition tracker, to put you in the fitness mode.

The online fitness and nutrition tracker is soon going to be your daily reckoner – you will be able to log in the amount of exercise done each day along with details of calories consumed. By the end of the day the data of the number of calories consumed and calories expended will be on your screen- so that you could do something about it.

According to Government statistics, about 195 million people are overweight, putting them under risk of diabetes, heart problems, high blood pressure, stroke and even cancer. The heart association is hopeful of a good participation from corporations in encouraging fitness amongst its employees. The association has suggested that organizations could promote fitness programs and reward employees for staying fit.



'"/>




Page: 1

Related medicine news :

1. Online information system for patients
2. Teens need to Exercise Caution While Using Online Blogs
3. Online recruitment criticised by doctors
4. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
5. NHS Downsizes Medication Goes Online
6. Online Sale of Abortion Pills
7. Premature Babies In ICU Can Be Viewed Online: Parents Rejoice
8. Anonymity Helps In Overcoming Inhibitions During Online Counseling
9. Online Auction Results In Purchase of Chemicals
10. Knee Injuries to be Treated Online
11. Online Medical Counseling In UP Lacks Transparency: Students
Post Your Comments:
Breaking Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 1Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 3Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 4Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 5Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 6Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study 5663 1Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study 5663 2NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 1NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 2NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer 5659 3
Other Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8